Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory Effects of Glycopyrronium in Allergic Asthma
NCT04259164Phase 3Completed
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glycopyrronium in allergic asthma, sponsored by University Medical Center Groningen. Started Sep 2020; status: completed.
02
Drugs
glycopyrronium
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT04259164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04259164.